Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.3889
-0.0092 (-2.31%)
At close: Jun 26, 2026, 4:00 PM EDT
0.390257
+0.0014 (0.35%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $4.07 million as of June 26, 2026. Its market cap has decreased by -49.42% in one year.
Market Cap
4.07M
Enterprise Value
3.56M
1-Year Change
-49.42%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $4.07M, a decrease of -85.47%. That is a compound annual growth rate of -9.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 4.07M | -50.46% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 4.58M |
| Alzamend Neuro | 4.57M |
| FibroBiologics | 4.46M |
| Creative Medical Technology Holdings | 4.44M |
| Ensysce Biosciences | 4.42M |
| 60 Degrees Pharmaceuticals | 4.28M |
| Matinas BioPharma Holdings | 4.12M |
| Artelo Biosciences | 3.90M |